CVS Earnings, Merger With Aetna Look Good to Investors

Health and Healthcare

Published: November 6, 2018 9:10 am

Last Updated: January 11, 2020 3:19 pm

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

CVS Health Corp. (NYSE: CVS) reported third-quarter results before markets opened Tuesday. The pharmacy retail operator posted quarterly adjusted diluted earnings per share (EPS) of $1.73 on revenues of $47.3 billion. In the same period a year ago, the company reported EPS of $1.50 on revenues of $46.18 billion. Third-quarter results also compare to the consensus estimates for EPS of $1.71 on revenues of $47.2 billion.

Same-store sales increased by 6.7% and pharmacy same-store sales increased 8.7% in the latest quarter. The increase in pharmacy same-store sales was driven primarily by an increase in pharmacy same-store prescription volumes, partially offset by continued reimbursement pressure and a negative impact of approximately 190 basis points due to recent generic introductions.

The company reiterated guidance for full-year adjusted EPS in a range of $6.98 to $7.08. Operating profit for the year is forecast to decline by 39% to 41% due to a goodwill impairment taken in the second quarter. Analysts had an estimate of $2.17 for fourth-quarter EPS on revenues of $49.29 billion. For the full year, analysts were looking for EPS of $7.04 and revenues of $188.9 billion.

CEO Larry Merlo said:

Strong revenue and adjusted EPS, along with significant cash flow year-to-date, demonstrate our success in driving value. Our year-to-date results continue to validate our confidence in the strength of our model. As we approach the closing of our transformative acquisition of Aetna, our integration teams are making great progress to assure that once final approvals are obtained, we can begin to execute on our integration plans.

The company’s proposed $70 billion acquisition of Aetna Inc. (NYSE: AET) received Department of Justice clearance last month following Aetna’s announcement in September that it would divest its Medicare drug business. The merger still requires approval from regulators in five states, and the company expects the deal to close before the Thanksgiving holiday.

Shares traded up more than 3.3% at one point in Tuesday’s premarket but have settled in around 2.3% about an hour before the opening bell at $75.11 in a 52-week range of $60.14 to $83.88. The consensus price target on the stock is $88.20.

ALSO READ: Why Big Dividend Energy Stocks May Be the Best End-of-2018 Bet

The Average American Is Losing Their Savings Every Day (Sponsor)

If you’re like many Americans and keep your money ‘safe’ in a checking or savings account, think again. The average yield on a savings account is a paltry .4% today, and inflation is much higher. Checking accounts are even worse.

Every day you don’t move to a high-yield savings account that beats inflation, you lose more and more value.

But there is good news. To win qualified customers, some accounts are paying 9-10x this national average. That’s an incredible way to keep your money safe, and get paid at the same time. Our top pick for high yield savings accounts includes other one time cash bonuses, and is FDIC insured.

Click here to see how much more you could be earning on your savings today. It takes just a few minutes and your money could be working for you.